IL149754A0 - Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same - Google Patents

Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same

Info

Publication number
IL149754A0
IL149754A0 IL14975400A IL14975400A IL149754A0 IL 149754 A0 IL149754 A0 IL 149754A0 IL 14975400 A IL14975400 A IL 14975400A IL 14975400 A IL14975400 A IL 14975400A IL 149754 A0 IL149754 A0 IL 149754A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
same
immunogenic portion
chlamydia antigen
compositions containing
Prior art date
Application number
IL14975400A
Other languages
English (en)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/556,877 external-priority patent/US6432916B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of IL149754A0 publication Critical patent/IL149754A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14975400A 1999-12-03 2000-12-04 Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same IL149754A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45468499A 1999-12-03 1999-12-03
US09/556,877 US6432916B1 (en) 1998-12-08 2000-04-19 Compounds and methods for treatment and diagnosis of chlamydial infection
US09/598,419 US6565856B1 (en) 1998-12-08 2000-06-20 Compounds and methods for treatment and diagnosis of chlamydial infection
PCT/US2000/032919 WO2001040474A2 (en) 1999-12-03 2000-12-04 Compounds and methods for treatment and diagnosis of chlamydial infection

Publications (1)

Publication Number Publication Date
IL149754A0 true IL149754A0 (en) 2002-11-10

Family

ID=27412613

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14975400A IL149754A0 (en) 1999-12-03 2000-12-04 Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same

Country Status (16)

Country Link
US (1) US6565856B1 (ja)
EP (1) EP1238084A2 (ja)
JP (1) JP2003515343A (ja)
KR (1) KR20020073136A (ja)
CN (1) CN1437652A (ja)
AU (1) AU1815901A (ja)
BR (1) BR0016066A (ja)
CA (1) CA2390088A1 (ja)
CZ (1) CZ20021897A3 (ja)
HU (1) HUP0203705A2 (ja)
IL (1) IL149754A0 (ja)
MX (1) MXPA02005504A (ja)
NO (1) NO20022592L (ja)
NZ (1) NZ518917A (ja)
PL (1) PL355977A1 (ja)
WO (1) WO2001040474A2 (ja)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219453A1 (en) * 1998-03-19 2003-11-27 Smithkline Beecham Biologicals, Sa Vaccines
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
AU5366099A (en) 1998-08-20 2000-03-14 Connaught Laboratories Limited Nucleic acid molecules encoding inclusion membrane protein of (chlamydia)
WO2000011180A1 (en) 1998-08-20 2000-03-02 Connaught Laboratories Limited NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA)
US6649370B1 (en) 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en) 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000032784A1 (en) 1998-12-01 2000-06-08 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
WO2000034483A2 (en) * 1998-12-08 2000-06-15 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6555115B1 (en) 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2356057A1 (en) 1998-12-28 2000-07-06 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
JP4832646B2 (ja) 1999-03-12 2011-12-07 サノフィ、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
JP4695763B2 (ja) 1999-05-03 2011-06-08 サノフィ、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
DE60037900T2 (de) 1999-09-20 2009-02-12 Sanofi Pasteur Ltd., Toronto Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP1240331B1 (en) 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20030175700A1 (en) * 2000-04-21 2003-09-18 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
EP1282718B1 (en) 2000-05-08 2006-12-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001276619A1 (en) 2000-07-03 2002-01-14 Chiron S.P.A. Immunisation against chlamydia pneumoniae
US7537772B1 (en) * 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
GB0103169D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US6925469B2 (en) * 2001-03-30 2005-08-02 Intertainer, Inc. Digital entertainment service platform
CA2469620A1 (en) 2001-12-12 2003-06-19 Chiron Srl. Immunisation against chlamydia trachomatis
GB0203403D0 (en) 2002-02-13 2002-04-03 Chiron Spa Chlamydia cytotoxic-T cell epitopes
CN102861325A (zh) * 2003-11-10 2013-01-09 Uab研究基金会 减少细菌携带和中枢神经系统侵害的组合物及其使用方法
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
EP2392348A3 (en) 2005-03-31 2012-01-18 GlaxoSmithKline Biologicals S.A. Vaccines against chlamydial infection
WO2007082105A2 (en) * 2006-01-16 2007-07-19 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chlamydia vaccine
WO2008022298A2 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Immunogenic pcpa polypeptides and uses thereof
NL1033345C1 (nl) 2007-02-06 2008-08-07 Vereniging Voor Christelijk Ho Werkwijze voor het detecteren van Chlamydia trachomatis en een kit daarvoor.
EP2517725A1 (en) * 2007-05-01 2012-10-31 Board Of Regents, The University Of Texas Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
WO2009020553A2 (en) * 2007-08-03 2009-02-12 President And Fellows Of Harvard College Chlamydia antigens
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
AU2008331800A1 (en) * 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
JP4798125B2 (ja) * 2007-12-13 2011-10-19 株式会社デンソー 照度センサ
WO2010042206A1 (en) 2008-10-09 2010-04-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
US8204859B2 (en) * 2008-12-10 2012-06-19 Commvault Systems, Inc. Systems and methods for managing replicated database data
EP2403526B1 (en) 2009-03-06 2019-05-15 GlaxoSmithKline Biologicals SA Chlamydia antigens
EP2557156B1 (en) 2010-03-23 2015-02-11 Wako Pure Chemical Industries, Ltd. Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same
CN112105376A (zh) 2018-03-08 2020-12-18 应用分子运输公司 用于经口递送的毒素衍生的递送构建体
WO2020096695A1 (en) * 2018-11-07 2020-05-14 Applied Molecular Transport Inc. Cholix-derived carriers for oral delivery of heterologous payload
TW202120521A (zh) 2019-08-16 2021-06-01 美商應用分子運輸公司 組合物、配方及介白素生產及純化
CN112779248B (zh) * 2021-02-04 2022-12-02 杭州遂曾生物技术有限公司 一种沙眼衣原体一体化核酸检测卡盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118469A (en) 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
US4497863A (en) 1984-03-07 1985-02-05 Milliken Research Corporation Laminated weft insertion fabric
US5166053A (en) 1990-02-23 1992-11-24 Miles Inc. Specimen adequacy control for chlamydia assays
JP3018553B2 (ja) 1990-05-08 2000-03-13 日立化成工業株式会社 クラミジア・トラコマティス抗体測定方法及びクラミジア・トラコマティス感染症診断用製剤
US5549978A (en) 1992-10-30 1996-08-27 Kabushiki Kaisha Toshiba Magnetoresistance effect element
US6165478A (en) 1994-09-20 2000-12-26 Hitachi Chemical Company, Ltd. DNA encoding Chlamydia pneumoniae antigenic polypeptide
GB9516293D0 (en) 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
NZ334114A (en) 1996-07-12 2000-06-23 Univ Manitoba DNA immunization against chlamydia infection comprising a major outer membrane protein (MOMP) or a MOMP fragment linked to a promoter sequence
US6464979B1 (en) 1996-09-12 2002-10-15 Aventis Pasteur Limited Chlamydial vaccines and methods of preparation thereof
ATE352624T1 (de) 1997-11-21 2007-02-15 Serono Genetics Inst Sa Chlamydia pneumoniae genomische sequenzen und polypeptiden, fragmenten und anwendungen davon für nachweis, prevention und heilung
EP2228385A1 (en) 1997-11-28 2010-09-15 Merck Serono Biodevelopment Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
NZ507378A (en) 1998-04-07 2002-12-20 Corixa Corp Fusion proteins of mycobacterium tuberculosis antigens and their uses
WO2000034483A2 (en) 1998-12-08 2000-06-15 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection

Also Published As

Publication number Publication date
CN1437652A (zh) 2003-08-20
NO20022592L (no) 2002-07-19
EP1238084A2 (en) 2002-09-11
US6565856B1 (en) 2003-05-20
HUP0203705A2 (hu) 2003-03-28
PL355977A1 (en) 2004-05-31
WO2001040474A2 (en) 2001-06-07
CA2390088A1 (en) 2001-06-07
WO2001040474A3 (en) 2002-03-07
CZ20021897A3 (cs) 2003-02-12
KR20020073136A (ko) 2002-09-19
MXPA02005504A (es) 2002-10-31
JP2003515343A (ja) 2003-05-07
NO20022592D0 (no) 2002-05-31
BR0016066A (pt) 2003-06-10
AU1815901A (en) 2001-06-12
NZ518917A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
IL149754A0 (en) Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same
IL142216A0 (en) A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same
IL150224A0 (en) Lipopeptides and pharmaceutical compositions containing the same
EG24044A (en) pharmaceutical formulation of omeprazole
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
AU7912100A (en) Pharmaceutical composition comprising an antigen
EP1254666A4 (en) STABLE ANTIBODY COMPOSITIONS AND INJECTION FORMULATIONS
PL343491A1 (en) Pharmaceutical aerosol formulation
PL331531A1 (en) Pharmaceutical aerosol compositions
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
IL146230A0 (en) 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0100470A3 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
IL145733A0 (en) A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same
AP2001002371A0 (en) Streptogramin derivatives preparation and compositions containing them
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
IL125908A (en) Peptides and pharmaceutical compositions comprising same
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
HUP0003330A3 (en) Pharmaceutical compositions containing tizoxanide and nitazoxanide
ZA9811470B (en) Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation
HK1046925A1 (zh) Mage-a12抗原肽及其用途
IL131266A0 (en) Peptides and pharmaceutical compositions comprising same
HRP970615B1 (en) Stabilized pharmaceutical compositions with quinupristine and dalfopristine base and their preparation